Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

DENTSPLY International Inc Add to portfolio

NAS:XRAY, Feb 24, 09:57 UTC

Latest NAS:XRAY News

Filter your feed

Apply Filter

Yesterday


News

DENTSPLY SIRONA Inc (XRAY) Shares Bought by Tower Research Capital LLC TRC – StockNewsTimes

XRAY

Bank of New York Mellon Corp boosted its holdings in shares of DENTSPLY SIRONA by 29.2% in the 4th quarter. Schroder Investment Management Group boosted its holdings in shares of DENTSPLY SIRONA by 20.2% in the 4th quarter. Stifel Nicolaus upped their target price on shares of DENTSPLY SIRONA from $66.00 to $70.00 and gave the company a “buy” rating in a report on Monday, November 6th. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 target price for the company in a report on Monday, November 6th.

Read Full Details

Topics:
  • Business
  • Financial
News

DENTSPLY SIRONA Inc (XRAY) Position Reduced by Folger Nolan Fleming Douglas Capital Management Inc. – registrarjournal.com

XRAY

Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $6,444,000 as of its most recent filing with the Securities & Exchange Commission. Folger Nolan Fleming Douglas Capital Management Inc. Decreases Holdings in DENTSPLY SIRONA Inc (XRAY) – BBNS. raised shares of DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 price objective for the company in a research note on Wednesday, December 13th. Zacks Investment Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, October 30th.

Read Full Details

Topics:
  • Business
  • Financial
News

DENTSPLY SIRONA Inc (XRAY) Stake Raised by Bank of New York Mellon Corp – Equities Focus

XRAY

Bessemer Group Inc. now owns 1,903,596 shares of the medical instruments supplier’s stock worth $113,855,000 after buying an additional 1,863,424 shares during the last quarter. Victory Capital Management Inc. now owns 855,955 shares of the medical instruments supplier’s stock worth $56,348,000 after acquiring an additional 852,168 shares during the period. raised DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 price objective for the company in a research report on Wednesday, December 13th. Credit Suisse Group cut DENTSPLY SIRONA to a “hold” rating and set a $73.00 price objective for the company.

Read Full Details

Topics:
  • Business
  • Financial
News

Analyzing Antares Pharma (ATRS) and DENTSPLY SIRONA (XRAY)

XRAY

This table compares Antares Pharma and DENTSPLY SIRONA’s top-line revenue, earnings per share and valuation. -16.41. DENTSPLY SIRONA has higher revenue and earnings than Antares Pharma. This table compares Antares Pharma and DENTSPLY SIRONA’s net margins, return on equity and return on assets. This is a breakdown of recent recommendations for Antares Pharma and DENTSPLY SIRONA, as reported by MarketBeat.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Thursday, February 22


News

Zacks: Brokerages Anticipate DENTSPLY SIRONA Inc (XRAY) Will Announce Quarterly Sales of $1.06 Billion – Week Herald

XRAY

HC Wainwright reaffirmed a “buy” rating and issued a $68.00 price target on shares of DENTSPLY SIRONA in a report on Monday, November 6th. Stifel Nicolaus raised their price target on DENTSPLY SIRONA from $66.00 to $70.00 and gave the stock a “buy” rating in a report on Monday, November 6th. raised its position in DENTSPLY SIRONA by 57.4% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its position in DENTSPLY SIRONA by 15.5% during the fourth quarter.

Read Full Details

Topics:
  • Business
  • Financial
News

DENTSPLY SIRONA Inc (XRAY) Stake Lessened by State of Wisconsin Investment Board – StockNewsTimes

XRAY

Bessemer Group Inc. lifted its stake in DENTSPLY SIRONA by 4,638.6% in the third quarter. Bessemer Group Inc. now owns 1,903,596 shares of the medical instruments supplier’s stock valued at $113,855,000 after purchasing an additional 1,863,424 shares during the last quarter. upgraded DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 price objective on the stock in a research note on Wednesday, December 13th. TheStreet upgraded DENTSPLY SIRONA from a “c” rating to a “b-” rating in a research note on Friday, November 3rd.

Read Full Details

Topics:
  • Business
  • Financial
News

DENTSPLY SIRONA Inc (XRAY) Announces Quarterly Dividend of $0.09

XRAY

DENTSPLY SIRONA Inc (NASDAQ:XRAY) declared a quarterly dividend on Wednesday, February 14th, RTT News reports. DENTSPLY SIRONA Inc (XRAY) Announces Quarterly Dividend of $0.09 – The Ledger Gazette. Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price objective on the stock in a report on Monday, November 6th. HC Wainwright reaffirmed a “buy” rating and set a $68.00 price objective on shares of DENTSPLY SIRONA in a report on Monday, November 6th.

Read Full Details

Topics:
  • Business
  • Financial
News

DENTSPLY SIRONA Inc (XRAY) Position Increased by Advisory Services Network LLC

XRAY

Grandfield & Dodd LLC boosted its holdings in shares of DENTSPLY SIRONA by 1.8% during the 3rd quarter. Thompson Siegel & Walmsley LLC boosted its holdings in shares of DENTSPLY SIRONA by 41.4% during the 3rd quarter. HC Wainwright cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 target price on the stock. DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $69.15. In related news, Director Eric Brandt sold 6,409 shares of the company’s stock in a transaction dated Monday, January 8th.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, February 21


News

Wetherby Asset Management Inc. Has $388,000 Stake in DENTSPLY SIRONA Inc (XRAY) – StockNewsTimes

XRAY

Victory Capital Management Inc. now owns 855,955 shares of the medical instruments supplier’s stock worth $56,348,000 after purchasing an additional 852,168 shares in the last quarter. Bessemer Group Inc. lifted its position in shares of DENTSPLY SIRONA by 4,638.6% during the 3rd quarter. Finally, Zacks Investment Research cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, January 8th. HC Wainwright cut DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 price target on the stock.

Read Full Details

Topics:
  • Business
  • Financial
News

Head-To-Head Survey: DENTSPLY SIRONA (XRAY) vs.

XRAY

This is a summary of current ratings and target prices for Antares Pharma and DENTSPLY SIRONA, as reported by MarketBeat. This table compares Antares Pharma and DENTSPLY SIRONA’s top-line revenue, earnings per share and valuation. This table compares Antares Pharma and DENTSPLY SIRONA’s net margins, return on equity and return on assets. DENTSPLY SIRONA beats Antares Pharma on 11 of the 17 factors compared between the two stocks.

Read Full Details

Topics:
  • Business
  • Health
  • Financial